A Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)

NCT00004845 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Alzheimer Disease

Interventions

DRUG: Rofecoxib
DRUG: Naproxen

Sponsor

National Institute on Aging (NIA)

Collaborators

[object Object]